Title : Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.

Pub. Date : 2005 Oct

PMID : 16178991






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nateglinide, a d-phenylalanine derivative, restores postprandial early phase insulin secretion in a transient and glucose-sensitive manner without affecting basal insulin levels. Nateglinide insulin Homo sapiens
2 The combination of nateglinide with insulin-sensitising agents, for example, metformin and thiazolidinediones, addresses the dual defects of loss of insulin secretion and insulin resistance to provide optimal management of type 2 diabetes, and more patients achieve HbA 1c goal with nateglinide combination therapy rather than with monotherapy with other oral agents. Nateglinide insulin Homo sapiens